Form 4: Dr. Fred B. Craves Reports Changes in Beneficial Ownership of Madrigal Pharmaceuticals Stock
SEC Filing
Dr. Fred B. Craves, a director of Madrigal Pharmaceuticals, reported a transaction involving company stock, including a gift of 15,000 shares.
Summary
- On September 13, 2024, Dr. Fred B. Craves, a director of Madrigal Pharmaceuticals, filed a Form 4 to report changes in his beneficial ownership of the company's stock.
- The reported transaction includes a gift of 15,000 shares of common stock.
- Following the transaction, Dr. Craves directly owns 360,076 shares.
- He also indirectly owns 11,210 shares through a grantor retained annuity trust, 1,261 shares through Bay City Capital LLC, and 18,000 shares through the Craves Family Foundation.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 09/13/2024 | Date of the reported transaction (gift of 15,000 shares). |
| 09/17/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.